Alerts

Acai Berry Living-XS Diet capsules pose a serious health risk and should not be taken. They contain undeclared sibutramine. This increases the risk of cardiac events and stroke.

Erec-Bull tablets pose a serious risk to your health and should not be taken. They contain undeclared yohimbine, which can pose serious health risks for people with underlying risk factors.

Questions and answers about Dextropropoxyphene

Consumers and health professionals are advised that Smith & Nephew, in consultation with the TGA, has issued a hazard alert regarding the femoral implant component of the Journey Bi-Cruciate Stabilised (BCS) knee replacement system.

Grease Discharging Machine Capsules pose a serious health risk and should not be taken. They contain undeclared sibutramine, sildenafil and beta‑asarone.

GlaxoSmithKline (GSK), in consultation with the TGA, is recalling two batches of Children's Panadol 1-5 years suspension from pharmacies and hospitals as a small proportion of bottles contain higher levels of paracetamol than specified.

LOVher capsules pose a serious risk to your health and should not be taken. The contain undisclosed tadalafil and sildenafil and have not been assessed by the TGA for quality, safety or efficacy.

Phen Tabz tablets are banned in Australia because they contain a hidden, dangerous chemical (DMAA) that can seriously harm your health.

The TGA advises that the distributor has initiated a recall of Slimming Factor pills (also known as Easy Trim, Que She and Chinese Herbal Diet Pills) as they pose a serious health risk.

OxyELITE Pro capsules (New Formula) pose a serious risk to your health and should not be taken. They contain yohimbine, which is a prohibited import.

New conditions for Di-Gesic and Doloxene (dextropropoxyphene) took effect on 10 October 2013 to ensure safe use, changing how these pain-killers are prescribed and supplied.

This update provides further specific information about the recall of Children's Panadol Baby Drops being undertaken by GlaxoSmithKline (GSK), in conjunction with the TGA, for a misaligned dosing syringe that could lead to accidental overdoses.

TGA safety alert on Children’s Panadol Baby Drops warns of potential dosing risks linked to syringe markings, advising careful measurement to avoid overdose in infants.

Recall due to potential for incorrect blood glucose results.

Recall due to potential for protruding needles.

Prosolution tablets are not approved for sale in Australia. Counterfeit versions of Prosolution tablets contain undeclared tadalafil and sildenafil. Both pose significant health risks if taken without medical advice.

Recall due to replacement due to potential for breakdown.

Vigor Tea poses a serious risk to your health and should not be taken. It contains undeclared sulfoaildenafil and has not been assessed for quality, safety or efficacy.

Recall due to replacement due to potential for miscalibration.

Monitoring communication

TGA warns that mefloquine (Lariam) may cause serious vision problems; seek medical advice if symptoms occur.

Consumers and health professionals are advised that Janssen-Cilag (Australia), in consultation with the TGA, is deregistering and discontinuing supply of oral ketoconazole (Nizoral) 200 mg tablets, commencing 1 December 2013.

New conditions on Di-Gesic and Doloxene (dextropropoxyphene) will change how these pain-killers are prescribed and supplied to ensure safe use from 10 October 2023.

Unlocated devices following recall for product correction.

Changes to radio frequency (RF) spectrums in Australia could affect a small number of biomedical telemetry devices used in hospitals.